CO5190666A1 - Procedimiento para la preparacion de aglomerados esfericos de telitromicina - Google Patents

Procedimiento para la preparacion de aglomerados esfericos de telitromicina

Info

Publication number
CO5190666A1
CO5190666A1 CO00062195A CO00062195A CO5190666A1 CO 5190666 A1 CO5190666 A1 CO 5190666A1 CO 00062195 A CO00062195 A CO 00062195A CO 00062195 A CO00062195 A CO 00062195A CO 5190666 A1 CO5190666 A1 CO 5190666A1
Authority
CO
Colombia
Prior art keywords
spherical
telitromycin
aglomerates
preparation
procedure
Prior art date
Application number
CO00062195A
Other languages
English (en)
Spanish (es)
Inventor
Jean-Yves Godard
Valerie Rognon
Original Assignee
Hoechst Marion Roussel Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=9549351&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CO5190666(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Hoechst Marion Roussel Inc filed Critical Hoechst Marion Roussel Inc
Publication of CO5190666A1 publication Critical patent/CO5190666A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682—Processes
    • A61K9/1688—Processes resulting in pure drug agglomerate optionally containing up to 5% of excipient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
CO00062195A 1999-08-26 2000-08-18 Procedimiento para la preparacion de aglomerados esfericos de telitromicina CO5190666A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9910810A FR2797875B1 (fr) 1999-08-26 1999-08-26 Agglomerats spheriques de telithromycine, leur procede de preparation et leur application dans la preparation de formes pharmaceutiques

Publications (1)

Publication Number Publication Date
CO5190666A1 true CO5190666A1 (es) 2002-08-29

Family

ID=9549351

Family Applications (1)

Application Number Title Priority Date Filing Date
CO00062195A CO5190666A1 (es) 1999-08-26 2000-08-18 Procedimiento para la preparacion de aglomerados esfericos de telitromicina

Country Status (34)

Country Link
US (1) US6825218B1 (enExample)
EP (1) EP1212336B1 (enExample)
JP (1) JP4871467B2 (enExample)
KR (1) KR100718222B1 (enExample)
CN (1) CN1183151C (enExample)
AR (1) AR025398A1 (enExample)
AT (1) ATE255590T1 (enExample)
AU (1) AU774385B2 (enExample)
BR (1) BR0013569B1 (enExample)
CA (1) CA2382497C (enExample)
CO (1) CO5190666A1 (enExample)
CZ (1) CZ2002594A3 (enExample)
DE (1) DE60006976T2 (enExample)
DK (1) DK1212336T3 (enExample)
EA (1) EA005080B1 (enExample)
ES (1) ES2209970T3 (enExample)
FR (1) FR2797875B1 (enExample)
HK (1) HK1049167B (enExample)
HR (1) HRP20020167B1 (enExample)
HU (1) HU229075B1 (enExample)
IL (2) IL148128A0 (enExample)
ME (2) MEP20108A (enExample)
MX (1) MXPA02001988A (enExample)
NO (1) NO322622B1 (enExample)
PL (1) PL204100B1 (enExample)
PT (1) PT1212336E (enExample)
RS (1) RS50433B (enExample)
SI (1) SI1212336T1 (enExample)
SK (1) SK287588B6 (enExample)
TR (1) TR200200506T2 (enExample)
TW (1) TWI272949B (enExample)
UA (1) UA73523C2 (enExample)
WO (1) WO2001014393A2 (enExample)
ZA (1) ZA200201599B (enExample)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9902202D0 (sv) * 1999-06-10 1999-06-10 Astra Ab Production of aggregates
FR2821747B1 (fr) * 2001-03-09 2004-07-02 Ethypharm Lab Prod Ethiques Suspension de telithromycine a gout masque
BR0215806A (pt) * 2002-07-19 2005-04-26 Aventis Pharma Sa Composição oral de telitromicina com paladar mascarado
WO2004009059A1 (en) * 2002-07-19 2004-01-29 Aventis Pharma S.A. Taste masked oral composition of telithromycin
US20040013737A1 (en) * 2002-07-19 2004-01-22 Philippe Becourt Taste masked oral composition of telithromycin
EP1610878B1 (en) * 2003-02-21 2014-09-03 University Of Bath Process for the production of particles
WO2005007143A2 (en) * 2003-07-14 2005-01-27 The Board Of Trustees Of The University Of Illinois Use of makrolides and ketolides for the treatment of tuberculosis
WO2007039914A2 (en) * 2005-10-06 2007-04-12 Alembic Limited Novel polymorphs of telithromycin
US20090075917A1 (en) * 2007-09-19 2009-03-19 Protia, Llc Deuterium-enriched telithromycin
KR101324862B1 (ko) * 2011-07-12 2013-11-01 (주)에이에스텍 클로피도그렐 황산수소염의 구형 입자, 이를 포함하는 약학적 조성물 및 이의 제조방법

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3468336D1 (en) * 1983-06-22 1988-02-11 Univ Ohio State Res Found Small particle formation
JPH02227130A (ja) * 1989-02-28 1990-09-10 Taisho Pharmaceut Co Ltd 球形微小凍結粒子の製造法
FR2719587B1 (fr) * 1994-05-03 1996-07-12 Roussel Uclaf Nouveaux dérivés de l'érythromycine, leur procédé de préparation et leur application comme médicaments.

Also Published As

Publication number Publication date
AU7018100A (en) 2001-03-19
CA2382497C (fr) 2011-06-28
CZ2002594A3 (cs) 2002-09-11
SK287588B6 (sk) 2011-03-04
SK2532002A3 (en) 2002-09-10
HK1049167B (zh) 2005-08-19
US6825218B1 (en) 2004-11-30
FR2797875B1 (fr) 2001-10-19
IL148128A (en) 2006-10-31
ATE255590T1 (de) 2003-12-15
UA73523C2 (uk) 2005-08-15
HUP0202842A3 (en) 2003-03-28
WO2001014393A3 (fr) 2001-06-21
KR100718222B1 (ko) 2007-05-15
NO20020926L (no) 2002-02-26
DK1212336T3 (da) 2004-03-15
CN1183151C (zh) 2005-01-05
DE60006976T2 (de) 2004-10-21
PL353137A1 (en) 2003-10-20
KR20020033771A (ko) 2002-05-07
HUP0202842A2 (hu) 2003-01-28
JP4871467B2 (ja) 2012-02-08
YU13202A (sh) 2004-09-03
CA2382497A1 (fr) 2001-03-01
MEP20108A (en) 2010-06-10
CN1371386A (zh) 2002-09-25
BR0013569A (pt) 2002-05-14
ME00112B (me) 2010-10-10
RS50433B (sr) 2009-12-31
ES2209970T3 (es) 2004-07-01
AR025398A1 (es) 2002-11-27
TR200200506T2 (tr) 2002-08-21
EA005080B1 (ru) 2004-10-28
MXPA02001988A (es) 2002-08-20
PT1212336E (pt) 2004-04-30
HK1049167A1 (en) 2003-05-02
ZA200201599B (en) 2003-04-30
HRP20020167B1 (en) 2006-06-30
DE60006976D1 (de) 2004-01-15
WO2001014393A2 (fr) 2001-03-01
TWI272949B (en) 2007-02-11
FR2797875A1 (fr) 2001-03-02
PL204100B1 (pl) 2009-12-31
IL148128A0 (en) 2002-09-12
EP1212336A2 (fr) 2002-06-12
HU229075B1 (hu) 2013-07-29
BR0013569B1 (pt) 2014-02-25
NO20020926D0 (no) 2002-02-26
HRP20020167A2 (en) 2003-06-30
SI1212336T1 (en) 2004-04-30
EP1212336B1 (fr) 2003-12-03
NO322622B1 (no) 2006-11-06
AU774385B2 (en) 2004-06-24
JP2003507484A (ja) 2003-02-25
EA200200294A1 (ru) 2002-08-29

Similar Documents

Publication Publication Date Title
Saroha et al. Transdermal gels-An alternative vehicle for drug delivery.
BR112023024646A2 (pt) Composto tetacíclico fundido, método de preparação do mesmo e aplicação do mesmo na medicina
JP2004536045A5 (enExample)
AR029174A1 (es) Derivados de espirooxindol, proceso para su preparacion, formulacion farmaceutica, y utilizacion de los derivados en la manufactura de medicamentos
ES2003139A6 (es) Procedimiento para preparar perlas para la obtencion de productos de liberacion controlada de farmacos.
DOP2000000114A (es) Oxazolidinonas substituidas y su uso
ATE307569T1 (de) Gelierbare pharmazeutische zusammensetzungen
BR0211801A (pt) Derivados de 7h-pirrolo[2,3-d]pirimidina
AR025959A1 (es) DERIVADOS DE TER.-BUTIL-(7-METIL-IMIDAZO[1,2,a]PIRIDIN-3-IL)-AMINA, PROCEDIMIENTO PARA SU PREPARACION, MEDICAMENTOS QUE LOS CONTIENEN, SU USO PARA LAPREPARACION DE UN MEDICAMENTO PARA LA INHIBICION DE NO-SINTASA Y COMPOSICIONES FARMACEUTICAS QUE LOS CONTIENEN
JP2013509440A5 (enExample)
RU2011130248A (ru) Применение фармацевтических композиций в изготовлении лекарственных средств для лечения диабетических язв
AR009741A1 (es) Nuevos derivados de la benzamidina, procedimiento para prepararlos, preparados farmaceuticos que los contienen y su empleo como medicamentos.
CN101518522A (zh) 大蒜素外用制剂及其制备方法
MX2013004099A (es) Conjunto de juguete de construccion.
JP2023551417A (ja) ブルシンゲルプラスター、その製造方法および使用
CN105030864B (zh) 一种经皮给药具有镇痛抗炎效果的药物组合物及其应用与制备方法
KR20200112012A (ko) (R)-진세노사이드 Rg3를 유효성분으로 포함하는 피부상처 치유 또는 피부재생 촉진용 조성물
CN103040792B (zh) 中药巴布剂的基质
SE0302572D0 (sv) Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof
AR025398A1 (es) Aglomerados esfericos de telitromicina, su procedimiento de preparacion y su aplicacion en la preparacion de formas farmaceuticas.
BR0014233A (pt) Conjugados de 4-benzilaminoquinolina com ácido galênico e seus heteroanálogos, processos para a sua preparação, medicamentos contendo estes compostos e sua aplicação
CN101618030B (zh) 一种雷公藤内酯醇透皮贴剂及其制备方法
PT94610A (pt) Processo para a obtencao de formulacoes topicas contendo derivados do acido metanodifosfonico
Shruthi Review: Pharmaceutical gels and its types with prominence role of its drug delivery systems
RU2605343C1 (ru) Средство для лечения гнойно-воспалительных процессов мягких тканей и слизистых оболочек

Legal Events

Date Code Title Description
FG Application granted